Quick search:
| Result | Content | Outlet | Published | Research |
|---|---|---|---|---|
| Result | Content | Outlet | Published | Research |
| 1 | Novartis' Sandoz launches first US generic to Roche's Esbriet | FiercePharma | 3 days ago | |
| 2 | Genentech, Inc. v. Sandoz, Inc. | Robins Kaplan LLP | JDSupra | 20 days ago | |
| 3 | Sandoz, Zolgensma, Drive Strong Q1 for Novartis | BioSpace | 21 days ago | |
| 4 | US Federal Circuit Swats Attempt To Block Sandoz's Pirfenidone | Generics Bulletin | 5 days ago | |
| 5 | Ares, Sandoz Extend Collaboration on Antimicrobial Resistance Surveillance, Treatment | GenomeWeb | 12 days ago | |
| 6 | Sandoz launches generic equivalent of AbbVie eyedrop Combigan in US | Medical Dialogues | 1 month ago | |
| 7 | Roche ends a bad, no good, plain lousy week with a $0 co-pay copycat stalking one of its blockbusters | Endpoints News | 8 hours ago | |
| 8 | Global Sepsis and Septic Shock Treatment Market Report 2022-2029 Featuring Pfizer, Johnson & Johnson, Sandoz, Teva, GSK, & Shanghai Pharmaceuticals Among Others | ResearchAndMarkets.com | 7 days ago | |
| 9 | Monopotassium Phospahte (MKP) Market Size 2022 Analysis by 2029 | Key Players – Sandoz, Pharmaceutical Associates, Master Plant-Prod, Prayon Group, Charkit Chemical – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 5 days ago | |
| 10 | Perphenazine Market Size And Forecast | Teva, Sandoz, Endo, Mylan, ZHPHARMA, Shandong Boshan Pharma – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 6 days ago | |
| 11 | Profitable Strategic Report on Quinidine Sulfate Market With Included Analysis of New Trends, Updates, and Forecast to 2028: Allure Remedies, IPCA Laboratories, Sandoz, Watson Laboratories, Intas Pharmaceuticals – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 4 days ago | |
| 12 | 6-Aminopenicillanic Acid(6-APA) Market Size And Forecast | Sandoz, DSM Sinochem Pharmaceuticals, CSPC Pharmaceutical Group, United Laboratories, Lvyuan Pharmaceutical – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 6 days ago | |
| 13 | Novartis' Sandoz bulks up in respiratory as strategic review of the generics outfit rolls on | FiercePharma | 2 months ago | |
| 14 | Levothyroxine Market Size And Forecast | Abbott Ltd, Alara Pharm (Sandoz), Forest (Actavis), Merck Serono, Piramal Healthcare, Mylan, KING PHARMS R AND D, Jerome Stevens – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 6 days ago | |
| 15 | Novartis may have a buyer for $21B generics unit Sandoz: report | FiercePharma | 6 months ago | |
| 16 | Global Donepezil Market 2022 Report Development Trends and Company Profile – Eisai, Pfizer, Teva, Sandoz – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 7 days ago | |
| 17 | No news anytime soon on Sandoz sale, says Novartis | - pharmaphorum | 3 months ago | |
| 18 | Is Sandoz spinoff finally here? Novartis gets the ball rolling with strategic review | FiercePharma | 7 months ago | |
| 19 | Perphenazine Drug Market Analysis, Research Study With Teva, Sandoz – SMU Daily Mustang | SMU Daily Mustang | 5 days ago | |
| 20 | Novartis sells pair of manufacturing plants as Sandoz strategic review rolls on | FiercePharma | 3 months ago | |
| 21 | Synthetic Opioids Drugs Market Recovery and Impact Analysis Report – Stada Arzneimittel, Sandoz, Pfizer – SMU Daily Mustang | SMU Daily Mustang | 5 days ago | |
| 22 | Lasix Market to Witness Huge Growth by 2029 | Mylan, Sanofi Aventis, Sandoz – SMU Daily Mustang | SMU Daily Mustang | 4 days ago | |
| 23 | Amoxicillin Trihydrate Market Size, Trends and Forecast to 2029 | DSM Sinochem, Sandoz, Asiatic Drugs & Pharmaceuticals, United Lab, Sanjiang Pharmaceutical. – SMU Daily Mustang | SMU Daily Mustang | 2 days ago | |
| 24 | Treprostinil Market to Witness Huge Growth by 2029 | United Therapeutics Corporation, Sandoz – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 5 days ago | |
| 25 | After settling criminal price-fixing case, Novartis' Sandoz inks $185M civil deal with feds | FiercePharma | 7 months ago | |
| 26 | Sandoz launches generic lenalidomide in 19 countries across Europe, expanding access to essential oncology medicine | Novartis | 3 months ago | |
| 27 | Global Retinal Biosimilars Market CAGR Status, Execute Growth Opportunities 2022-2029 | Novartis (Sandoz), Takeda, Bayer, Genentech, Pfenex – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 5 days ago | |
| 28 | Novartis' Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone | FiercePharma | 3 months ago | |
| 29 | Swiss socialists say government should buy Sandoz | - pharmaphorum | 6 months ago | |
| 30 | Novartis CEO Narasimhan confirms interest in purchase of generics unit Sandoz: report | FiercePharma | 5 months ago | |
| 31 | Vitamin D Deficiency Treatment Market Size And Forecast | Glanbia, Reckitt Benkiser, BASF, Pfizer, Sandoz, Cipla, Mankind Pharma, Merk, Sun Pharmaceuticals – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 4 days ago | |
| 32 | Sandoz, Inc. Issues Nationwide Recall of One Lot of Enoxaparin Sodium Injection, USP 40mg/0.4 mL Due to Temperature Excursion During Shipping | FDA.gov | 6 months ago | |
| 33 | Sandoz, Inc. Issues Nationwide Recall of 13 Lots of Orphenadrine Citrate 100 mg Extended Release Tablets Due to Presence of a Nitrosamine Impurity | FDA.gov | 2 months ago | |
| 34 | Nasal Sprays Market Share, Industry Size, Leading Company Outlook, Upcoming Challenges and Opportunities to 2028 | ADAPT Pharma, Sandoz International GmbH, Cipla – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 6 days ago | |
| 35 | Industry Experts Predict Biologics CDMO Market Will Hit $31M By 2030 | BioSpace | 4 days ago | |
| 36 | Microscopic Polyangiitis(MPA) Treatment Market Size And Forecast | Key Players – Celltrion Inc, ChemoCentryx Inc, Sandoz International GmbH, Teijin Pharma Ltd, TTY Biopharm Company Ltd – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 4 days ago | |
| 37 | Monopotassium Phosphate Market is Booming Worldwide with Sandoz, Pharmaceutical Associates – ManufactureLink | ManufactureLink | 5 days ago | |
| 38 | Delpharm Acquires Sandoz Sterile Injectable Production Facility | Contract Pharma | 4 months ago | |
| 39 | Hydroxychloroquine Sulfate Market Outlook: Post Covid-19 Scenario by 2029 | Concordia Healthcare, Mylan, Sandoz – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 5 days ago | |
| 40 | Sandoz extends collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR) | Novartis | 1 month ago | |
| 41 | Megestrol Market 2022 Development Status – Pfizer, Sandoz, GSK – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 5 days ago | |
| 42 | Genentech suffers loss in Esbriet patent dispute with Sandoz, Teva and more | FiercePharma | 2 months ago | |
| 43 | Lansoprazole Market Set to Witness Explosive Growth by 2029 | Lepu Pharmaceuticals, Krka, Sandoz – SMU Daily Mustang | SMU Daily Mustang | 5 days ago | |
| 44 | Amgen v. Sandoz Pharma Case | The National Law Review | 4 months ago | |
| 45 | Novartis CEO: Setting Up Sandoz for Next Wave of Growth | Bloomberg | 3 months ago | |
| 46 | Novartis' Sandoz, following Pfizer's lead, launches 2nd carcinogen-related drug recall this week | FiercePharma | 2 months ago | |
| 47 | Sandoz submits BLA for breast and gastric cancer targeted biosimilar drug | BioPharma-Reporter.com | 5 months ago | |
| 48 | Sandoz in oncology biosimilar deal with China's Bio-Thera | BioPharma-Reporter.com | 8 months ago | |
| 49 | Recombinant Peptide Market Report Covers Future Trends With Research 2022 to 2029 – Sandoz Pharma, Biocon Ltd. – SMU Daily Mustang | SMU Daily Mustang | 5 days ago | |
| 50 | Boehringer Bids To Go Beyond Slowing IPF | Scrip | 6 hours ago | |
| 51 | US Biosimilar Market Size, Trends and Forecast to 2029 | Novartis Ag, Mylan NV, Coherus Biosciences Inc, AbbVie Inc, Pfizer Inc, Sandoz, Teva Pharmaceutical, Eli Lilly & Company, Celltrion Inc and Amgen Inc. – SMU Daily Mustang | SMU Daily Mustang | 2 days ago | |
| 52 | Teva, Sandoz have launched Narcan generics, but Emergent's branded option should still thrive: analysts | FiercePharma | 4 months ago | |
| 53 | Novartis' Sandoz settles with Novo Nordisk for 2024 launch of third Victoza generic | Endpoints News | 2 months ago | |
| 54 | Sandoz, Ilsung to co-promote neuromuscular agent < Pharma < 기사본문 | KBR | 2 months ago | |
| 55 | Sandoz launches authorized generic of Narcan® (naloxone hydrochloride) Nasal Spray 4 mg in US to help reverse opioid overdose, expanding access during surge in overdose deaths | PR Newswire | 5 months ago | |
| 56 | Biosimilar Spinoffs: Organon Earnings and Sandoz' "Strategic Review" | The Center for Biosimilars | 6 months ago | |
| 57 | Sandoz Executive Talks About Cost Savings From Biosimilar Insulins — and the Challenges | Managed Healthcare Executive | 5 months ago | |
| 58 | Sandoz and Teva invalidate blockbuster apixaban patent and SPC | JUVE Patent | 1 month ago | |
| 59 | Novartis' Scemblix Shines at ASH While Sandoz Rumors Swirl | BioSpace | 5 months ago | |
| 60 | LIDW22: Collaboration at the heart of life sciences and offshore disputes | ICLG.com | 4 hours ago | |
| 61 | Global Dry Powder Inhaler Devices Market Size 2022-2027 | Key-players- Bayer HealthCare, GlaxoSmithKline, Sandoz Internationa – SMU Daily Mustang | SMU Daily Mustang | 5 days ago | |
| 62 | Sandoz CEO Saynor Signals No Change To Focus Amid Strategic Review | In Vivo | 6 months ago | |
| 63 | Amgen scores Otezla patent win, protecting its blockbuster from Sandoz and Zydus generics until 2028 | FiercePharma | 8 months ago | |
| 64 | Sandoz completes acquisition of GSK's cephalosporin business | PMLiVE | 7 months ago | |
| 65 | Sandoz submits BLA for proposed biosimilar trastuzumab to the FDA | JD Supra | 5 months ago | |
| 66 | Sandoz Canada launches PrSandoz® Lenalidomide, a generic equivalent to PrRevlimid | GlobeNewswire | 9 months ago | |
| 67 | Human Growth Hormone Drugs Market – A Comprehensive Study by Key Players: Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US), GeneScience Pharmaceuticals Co., Ltd. (China), Merck KgaA (Germany), Novo Nordisk A/S | ManufactureLink | 2 days ago | |
| 68 | Sandoz announces plans to further strengthen its antibiotics manufacturing setup in Europe | GlobeNewswire | 12 months ago | |
| 69 | US: Sandoz sees route to market with Enbrel biosimilar blocked for eight more years | BioPharma-Reporter.com | 12 months ago | |
| 70 | Sandoz and Aequus Agree to 1-Year Extension on Vistitan in Canada | GlobeNewswire | 4 months ago | |
| 71 | Bachelor’s Liz Sandoz Gives Birth, Welcomes 2nd Baby With Husband Vito Presta: See Photo | Us Weekly | 2 months ago | |
| 72 | Careers in Manufacturing and Supply | Novartis | 20 days ago | |
| 73 | Teva And Sandoz Go Head-To-Head On US Narcan | Generics Bulletin | 5 months ago | |
| 74 | Sandoz launches first generic high dose intravenous iron, Ferumoxytol Injection, to treat US patients with iron deficiency anemia | PR Newswire | 10 months ago | |
| 75 | Contributor: The Enemy of Your Enemy Should Be Your Friend – Why Biosimilars Companies Should Collaborate | The Center for Biosimilars | 7 days ago | |
| 76 | Sandoz launches its first RFID-tagged critical injectable medicines with Kit Check to optimize supply chain and automate restocking in US hospitals | Sandoz | Novartis | 2 years ago | |
| 77 | Sandoz Canada launches PrSandoz® Dimethyl Fumarate Delayed-Release Capsules, a generic equivalent to PrTecfidera | GlobeNewswire | 7 months ago | |
| 78 | Calcium Sandoz — For 90s kids, the happy-puppy bottle scored over health benefits of the pills | ThePrint | 9 months ago | |
| 79 | Sandoz Recalls Potentially Carcinogenic Muscle Pain Pills | MedTruth | 1 month ago | |
| 80 | Sandoz Egypt launches 'Linex' probiotic to support balance and function of intestinal microflora | Daily News Egypt | 1 month ago | |
| 81 | Sandoz Canada congratulates the Quebec government on implementing a shift towards biosimilars | GlobeNewswire | 12 months ago | |
| 82 | Sandoz Victoza Settlement Sets Up Face-Off With Teva And Viatris | Generics Bulletin | 1 month ago | |
| 83 | AstraZeneca, MSD sue MSN and Sandoz over Calquence generics | Life Sciences Intellectual Property Review | 3 months ago | |
| 84 | Sandoz Resolves Generic Drug Antitrust Investigation in the US | Novartis | 2 years ago | |
| 85 | A meaningful life is possible amid suffering, some therapists say | The Washington Post | 3 months ago | |
| 86 | Sandoz Launches Sixth Biosimilar in Canada | AJMC.com Managed Markets Network | 12 months ago | |
| 87 | Sandoz Partner Gan & Lee Wraps Phase III Insulin Glargine Trial | Generics Bulletin | 7 months ago | |
| 88 | Ramipril Sandoz (Ramipril) Drug / Medicine Information | News-Medical.Net | 7 months ago | |
| 89 | In major shake-up, Novartis combines pharma and oncology units, leaving 3 top execs without jobs | FiercePharma | 1 month ago | |
| 90 | Sandoz Canada launches its 6th biosimilar with Inclunox® and Inclunox® HP (Enoxaparin sodium solution for injection 100 mg/mL and 150 mg/mL (High Potency)) | GlobeNewswire | 12 months ago | |
| 91 | Sandoz working to overcome barriers to greater biosimilars uptake in US | BioPharma-Reporter.com | 2 years ago | |
| 92 | Sandoz completes acquisition of Aspen's Japanese operations, strengthening its position in world's third largest market for generics and off-patent medicines | Sandoz | Novartis | 2 years ago | |
| 93 | Sandoz Aims To Be 'First In And Last Out' In North America | Generics Bulletin | 1 year ago | |
| 94 | Sandoz to Start Phase 3 Trial of Aflibercept Biosimilar | The Center for Biosimilars | 1 year ago | |
| 95 | Novartis subsidiary Sandoz to pay $195 million over antitrust allegations | CNBC | 2 years ago | |
| 96 | Sandoz responds to increased demand for antibiotics and other essential medicines for patients during COVID-19 | Novartis | 2 years ago | |
| 97 | Novartis' Sandoz chief exits with 'de-integration' undone. Could a spinoff be next? | FiercePharma | 3 years ago | |
| 98 | Sandoz incorporates RFID technology on injectables | OutSourcing-Pharma.com | 2 years ago | |
| 99 | Sandoz reviewing options after Federal Circuit upholds lower court ruling in biosimilar Erelzi® case | Novartis | 2 years ago | |
| 100 | Best Ever Jambalaya with Chef Gaye Sandoz | KTALnews.com | 3 months ago |